Alzheimers disease Trials in Toronto, Canada
Conditions / Alzheimers disease / Toronto, Canada
Alzheimers disease is a medical condition with active clinical research programs worldwide.
13 total trials for this combination
Showing top 10 of 13 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT07169578 | A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease | RECRUITING | PHASE3 |
| NCT07177352 | Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies | RECRUITING | PHASE3 |
| NCT02565511 | A Study of CAD106 and CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease | TERMINATED | PHASE2/PHASE3 |
| NCT04623242 | Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation. | COMPLETED | PHASE2/PHASE3 |
| NCT05269394 | Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation (DIAN-TU) | ACTIVE_NOT_RECRUITING | PHASE2/PHASE3 |
| NCT01760005 | Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation. Master Protocol DIAN-TU-001 | ACTIVE_NOT_RECRUITING | PHASE2/PHASE3 |
| NCT07170150 | A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease | RECRUITING | PHASE3 |
| NCT03131453 | A Study of CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease | TERMINATED | PHASE2/PHASE3 |
| NCT06647498 | A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation | RECRUITING | PHASE2/PHASE3 |
| NCT05552157 | A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation | RECRUITING | PHASE2/PHASE3 |